Related references
Note: Only part of the references are listed.Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease
Marcin Krawczyk et al.
HEPATOLOGY (2012)
Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: Where are we for cholesterol gallstone formation?
Piero Portincasa et al.
HEPATOLOGY (2012)
Niemann-Pick C2 Protein Expression Regulates Lithogenic Diet-Induced Gallstone Formation and Dietary Cholesterol Metabolism in Mice
Elisa Balboa et al.
LIPIDS (2012)
Long-term Statin Use and the Risk of Gallstone Disease: A Population-based Case-Control Study
Rune Erichsen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Dissecting the Genetic Heterogeneity of Gallbladder Stone Formation
Marcin Krawczyk et al.
SEMINARS IN LIVER DISEASE (2011)
Triglycerides and gallstone formation
A. H. M. Smelt
CLINICA CHIMICA ACTA (2010)
Lith Genes and Genetic Analysis of Cholesterol Gallstone Formation
Helen H. Wang et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Epidemiology of Gallstones
Laura M. Stinton et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Statin Use and the Risk of Cholecystectomy in Women
Chung-Jyi Tsai et al.
GASTROENTEROLOGY (2009)
Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy
Michael Bodmer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Biliary lipids and cholesterol gallstone disease
David Q-H. Wang et al.
JOURNAL OF LIPID RESEARCH (2009)
Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters
Mark A. Valasek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones
Helen H. Wang et al.
GASTROENTEROLOGY (2008)
Coordinate regulation of gallbladder motor function in the gut-liver axis
Piero Portincasa et al.
HEPATOLOGY (2008)
Physical chemistry of intestinal absorption of biliary cholesterol in mice
David Q. -H. Wang et al.
HEPATOLOGY (2008)
Ezetimibe prevents cholesterol gallstone formation in mice
Silvia Zuniga et al.
LIVER INTERNATIONAL (2008)
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetirnibe
Ryan E. Temel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Gallbladder disease is associated with insulin resistance in a high risk Hispanic population
Flavio Nervi et al.
JOURNAL OF HEPATOLOGY (2006)
Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine
HH Wang et al.
HEPATOLOGY (2005)
High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice
DQH Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines
SM Grundy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals
T Feldman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
The use of simvastatin for the prevention of gallstones in the lithogenic prairie dog model
KG Davis et al.
OBESITY SURGERY (2003)
The safety and immunogenicity of a CETP vaccine in healthy adults
MH Davidson et al.
ATHEROSCLEROSIS (2003)
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial
CM Ballantyne et al.
CIRCULATION (2003)
Effect of β-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice
DQH Wang et al.
JOURNAL OF LIPID RESEARCH (2002)
Inhibition of intestinal cholesterol absorption by ezetimibe in humans
T Sudhop et al.
CIRCULATION (2002)
Lovastatin alters biliary lipid composition and dissolves gallstones - A long-term study in prairie dogs
MZ Abedin et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-B1
DQH Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism
CG Hillebrant et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia
T Sudhop et al.
DRUGS (2002)
Orlistat inhibits dietary cholesterol absorption
B Mittendorfer et al.
OBESITY RESEARCH (2001)
Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively
D Hunninghake et al.
ATHEROSCLEROSIS (2001)
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: A 24-week randomized controlled trial
W Insull et al.
MAYO CLINIC PROCEEDINGS (2001)
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies
HE Bays et al.
CLINICAL THERAPEUTICS (2001)
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia
W Insull et al.
ATHEROSCLEROSIS (2001)
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters
M van Heek et al.
DIABETES (2001)
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
M van Heek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation epidemiological - Study in an unselected population
FX Caroli-Bosc et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice
KK Buhman et al.
NATURE MEDICINE (2000)
Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones
JL Smith et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet
L Amigo et al.
GASTROENTEROLOGY (2000)
Share Paper
